These awards provide up to £100,000 over two years and a personalised package of career support to help newly independent biomedical scientists to launch their research careers.

Key dates

Round 3 has closed. The selection panel will meet in December 2017 and applicants will be informed of the outcome of their applications by the end of January 2018.

Round 4 will open in Spring/Summer 2018.



Springboard offers a bespoke package of support to biomedical researchers at the start of their first independent post to help launch their research careers. This includes funding of up to £100,000 over two years and access to the Academy’s acclaimed mentoring and career development programme.

About the scheme

In 2012, the Academy convened a Task Force, chaired by Professor Martin Humphries FMedSci, to examine ways for the Academy to further support early career researchers. Amongst other findings, the Task Force recommended the development of a funding scheme for non-clinical biomedical scientists.

Scoping work carried out by the Academy identified Lecturers, or equivalent, within the first three years of starting their post and who had not yet obtained significant funding as being in greatest need of support. The limited start-up packages normally provided and paucity of grant schemes available at this career stage makes establishing an independent research programme particularly challenging. 

In May 2015, the Academy partnered with the Wellcome Trust to initiate the Academy of Medical Sciences Springboard - a scheme to support biomedical researchers newly appointed to their first independent position. In 2017 we were delighted to welcome the British Heart Foundation and the Government Department of Business, Energy and Industrial Strategy, alongside the Wellcome Trust, to form a funding consortium  for the scheme. The scheme seeks to embrace the breadth of biomedical research and welcomes applications that contribute to the Academy’s mission to improve health through research.

Recent Awardees

Dr Kate Baker, University of Liverpool: Multi-species models of antimicrobial resistance emergence and persistence, developed from real world epidemics.

Dr Marcella Bassetto, Cardiff University: Novel therapeutic strategies to overcome opsin misfolding and aggregation in retinal blinding diseases.

Dr Tim Blower, Durham University: Regulating bacterial growth through toxin-antitoxin systems.

Dr Peter Cook, University of Manchester: Defining the key human innate immune cells that control anti-fungal immunity and inflammation.

Dr Laura Ferraiuolo, University of Sheffield: The involvement of exosomal RNA in astrocyte-mediated toxicity in motor neurone disease.

Dr Juan Fontana, University of Leeds: Elucidating the structure of previously inaccessible fusion intermediates of Influenza A Virus by cryo-electron microscopy.

Dr James Garnett, Queen Mary, University of London: A multidisciplinary approach to identify new antibacterial targets within biofilms.

Dr Katie Gillies, University of Aberdeen: Feedback matters: How should trial results be reported back to participants?

Dr Jamie Johnston, University of Leeds: Optical mapping of olfactory circuitry.

Dr Antreas Kalli, University of Leeds: Membrane transport proteins: Understanding the red cell Band 3 anion exchanger function

Dr Peter Keating, University College London: Developmental impact of intermittent hearing loss on spatial hearing in noisy environments.

Dr Tiziana Lembo, University of Glasgow: Understanding cultural, social and epidemiological drivers of human anthrax infection in rural African communities.

Dr David Llobet-Navas, Newcastle University: Control of somatic reprogramming by the microRNA cluster-424/503 during breast tumorigenesis and its relation with pregnancy.

Dr Christian Nielsen, Queen Mary University of London: Organic Bioelectronic Sensors for Epilepsy Diagnosis.

Dr Michael Okun, University of Leicester: How do individual neurons engage in resting-state infraslow dynamics of the cortex?

Dr Alice Pollitt, University of Reading: Impact of Podoplanin signalling complexes on the separation of the lymphatic and blood vasculatures in vivo.

Dr Andela Saric, University College London: Amyloid aggregation: Inhibition of self-replication and membrane-mediated control.

Dr Inez Schoenmakers, University of East Anglia: Does vitamin D supplementation have anabolic effects on the osteocyte and does it benefit the renal-bone axis?

Dr Amanda Sferruzzi-Perri, University of Cambridge: Materno-fetal resource allocation; altering placental endocrine function by IGF2.

Dr Yihua Wang, University of Southampton: The role of Factor inhibiting HIF (FIH) in the development of idiopathic pulmonary fibrosis (IPF).


The scheme is generously supported by the Wellcome Trust, British Heart Foundation and the Government Department for Business, Energy and Industrial Strategy.

Staff leads

Horizon scanning workshop - Birmingham

Book Now

Horizon scanning workshop - Leeds

Book Now

Bridging the preclinical-clinical boundary: How can we ensure that the UK remains at the forefront of discovering and developing medicines?

Book Now
View more